Pure Lab Peptides Retatrutide (20 mg) product page (quality specifications, batch documentation, supplier information) Related research, protocols, and guides Explore the available research context, protocol variants or comparisons, and practical guides
GLP-1 Receptor Activation This is the same pathway used by Semaglutide (Ozempic, Wegovy): Suppresses appetite via hypothalamic signaling Delays gastric emptying , prolonging fullness Improves insulin secretion and glucose control Lowers postprandial glucose and insulin resistance GIP Receptor Activation Shared with Tirzepatide, GIP provides several synergistic effects: Enhances insulin release in response to meals May reduce GI side effects (like nausea) seen with GLP-1s alone Potentially improves lipid metabolism and adipose tissue response Glucagon Receptor Activation This is where Retatrutide takes a leap beyond dual agonists: Increases energy expenditure and fat oxidation Mobilizes stored fat through hepatic lipolysis May preserve or enhance lean mass during weight loss Supports brown fat activation and thermogenesis The addition of glucagon receptor activation to GLP-1 and GIP may enhance fat oxidation and energy burn beyond whats seen with dual agonists. Coskun et al., Cell Metabolism Together, these pathways work synergistically: GLP-1 blunts hunger , GIP improves insulin dynamics , and glucagon turns up fat-burning efficiency
Vitamins A, C, and D are enzymatic cofactors that facilitate wound healing, collagen synthesis, and remodeling
Speak with your pharmacist or provider for exact pricing
The MHRA safety guidance emphasises that GLP-1 receptor agonists should only be used under medical supervision with appropriate monitoring
Indeed, when the IGF-1R was knocked down in vitro , exendin-4 lost the ability to activate this pathway, suggesting that GLP-1 analogues may restore -cell proliferation via autocrine or paracrine activation of IGF-1R (44)
